Used as a predictive biomarker, the first-of-its-kind VENTANA MMR RxDx Panel helps identify cancer patients eligible for treatment with certain precision oncology therapies By evaluating a panel of MMR proteins in tumours, the test provides clinicians with a standardised testing option to...
Hence then, the article about roche s ventana mmr rxdx panel companion diagnostic receives ivdr approval across multiple cancer types and therapies was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies )
Also on site :
- Bisignano says Social Security Administration’s phone helpline wait times have reached a record low
- Fans Choose Shakira & Burna Boy’s ‘Dai Dai’ as Best World Cup Song of All Time: Full Results
- How I Cracked the Tween Vacation Code at This Hidden Williamsburg Resort